PortfoliosLab logo
Virtus LifeSci Biotech Clinical Trials ETF (BBC)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

ETF Info

ISIN

US26923G3011

CUSIP

26923G301

Inception Date

Dec 16, 2014

Region

North America (U.S.)

Leveraged

1x

Index Tracked

LifeSci Biotechnology Clinical Trials Index

Asset Class

Equity

Asset Class Size

Multi-Cap

Asset Class Style

Blend

Expense Ratio

BBC has an expense ratio of 0.79%, placing it in the medium range.


Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart


Loading data...

Returns By Period

Virtus LifeSci Biotech Clinical Trials ETF (BBC) returned -27.83% year-to-date (YTD) and -34.26% over the past 12 months. Over the past 10 years, BBC returned -6.01% annually, underperforming the S&P 500 benchmark at 10.46%.


BBC

YTD

-27.83%

1M

16.44%

6M

-43.79%

1Y

-34.26%

5Y*

-15.79%

10Y*

-6.01%

^GSPC (Benchmark)

YTD

-3.77%

1M

7.44%

6M

-5.60%

1Y

8.37%

5Y*

14.12%

10Y*

10.46%

*Annualized

Monthly Returns

The table below presents the monthly returns of BBC, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-3.85%-11.63%-13.78%8.84%-9.48%-27.83%
20243.81%18.46%-3.12%-10.43%1.62%-4.73%14.23%-2.88%-0.29%1.75%-3.40%-11.94%-1.10%
202310.58%-9.56%-12.29%5.00%5.69%-1.50%0.52%-10.85%-8.61%-8.99%9.85%25.08%-1.80%
2022-22.31%-4.80%-1.94%-21.07%-12.26%11.61%11.18%5.54%-3.01%5.28%-1.60%-1.85%-35.13%
20216.07%3.39%-5.53%-1.30%-5.29%4.00%-11.60%8.13%-4.27%-2.93%-8.49%-5.10%-22.31%
2020-7.00%-3.78%-13.95%20.84%16.22%4.96%-10.11%4.18%-3.63%-0.50%21.14%5.54%30.32%
20197.86%6.59%6.63%-2.50%-4.61%8.75%-3.35%-4.80%-10.12%10.73%22.04%18.21%63.81%
201814.32%1.84%-0.93%-5.28%11.69%-5.76%-0.10%9.52%-3.38%-22.35%2.14%-15.25%-18.29%
20177.77%10.79%5.50%-2.41%-7.37%14.59%0.83%14.12%5.46%-4.58%1.56%1.74%56.12%
2016-33.91%-10.10%10.37%3.78%5.92%-14.04%10.56%0.60%13.14%-19.90%9.33%-7.19%-36.63%
20153.79%7.92%5.68%-8.61%19.30%1.17%-0.13%-13.86%-15.34%3.83%15.66%-7.84%5.25%
20143.90%3.90%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of BBC is 1, meaning it’s performing worse than 99% of other ETFs on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of BBC is 11
Overall Rank
The Sharpe Ratio Rank of BBC is 11
Sharpe Ratio Rank
The Sortino Ratio Rank of BBC is 11
Sortino Ratio Rank
The Omega Ratio Rank of BBC is 11
Omega Ratio Rank
The Calmar Ratio Rank of BBC is 22
Calmar Ratio Rank
The Martin Ratio Rank of BBC is 11
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Virtus LifeSci Biotech Clinical Trials ETF (BBC) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Virtus LifeSci Biotech Clinical Trials ETF Sharpe ratios as of May 11, 2025 (values are recalculated daily):

  • 1-Year: -0.91
  • 5-Year: -0.37
  • 10-Year: -0.16
  • All Time: -0.10

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of Virtus LifeSci Biotech Clinical Trials ETF compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time. For deeper analysis or to customize the calculation, use the Sharpe ratio tool.


Loading data...

Dividends

Dividend History

Virtus LifeSci Biotech Clinical Trials ETF provided a 1.39% dividend yield over the last twelve months, with an annual payout of $0.24 per share.


0.00%0.20%0.40%0.60%0.80%1.00%$0.00$0.05$0.10$0.15$0.20$0.25$0.302015201620172018201920202021202220232024
Dividends
Dividend Yield
PeriodTTM2024202320222021202020192018201720162015
Dividend$0.24$0.24$0.08$0.00$0.00$0.00$0.00$0.00$0.30$0.00$0.15

Dividend yield

1.39%1.00%0.34%0.00%0.00%0.00%0.00%0.00%1.04%0.00%0.51%

Monthly Dividends

The table displays the monthly dividend distributions for Virtus LifeSci Biotech Clinical Trials ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025$0.00$0.00$0.00$0.00$0.00$0.00
2024$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.24$0.24
2023$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.08$0.08
2022$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2021$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2020$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2019$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2018$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2017$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.30$0.30
2016$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2015$0.15$0.15

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the Virtus LifeSci Biotech Clinical Trials ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Virtus LifeSci Biotech Clinical Trials ETF was 76.85%, occurring on Apr 8, 2025. The portfolio has not yet recovered.

The current Virtus LifeSci Biotech Clinical Trials ETF drawdown is 71.71%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-76.85%Feb 9, 20211046Apr 8, 2025
-58.5%Jul 20, 2015328Nov 3, 2016788Dec 23, 20191116
-40.47%Dec 26, 201957Mar 18, 202037May 11, 202094
-16.61%Jun 24, 202053Sep 8, 202057Nov 27, 2020110
-15.83%Mar 20, 201529Apr 30, 201520May 29, 201549

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...